Eli Lilly and Company: The Flexible Facility Decision (1993)
Report On
Eli Lilly and Company:
The Flexible Facility Decision (1993)
As part of the Course “Managerial Written Communication”
Eli-Lilly and Company
Indianpolis
Indaina USA
November 1993
To Manufacturing Strategy Committee
Eli-Lilly and Company
Indiana, USA
From Mr Steve Muller
Manager, Strategic Facilities Planning
Eli-Lilly and Company
Indiana, USA
Sub:- Decision Report on choice of facility
Dear Committee Members,
I am submitting herewith the decision report on the choice of facility for the production of Alfatine, Betazine and Clorazine.
I hope you will find this report satisfactory.
In case any further clarification is needed I would be highly obliged to help you.
Mr Steve Muller
Manager, Strategic Facilities Planning
Eli-Lilly and Company
Contact:-######
Decision Summery
In the changing business environment of pharmaceutical industries, ELC is required to take strategic decision on the choice of facility for the production of drugs which are expected to be launched in 1996, which will help ELC to achieve its strategic goals.
Options of erecting one specialized facility or one flexible facility have been evaluated on the basis of effect on manufacturing cost, effect on lead time and mitigation of risks.
It is recommended to erect one flexible plant initially and then if demand of any product increases sufficiently, build one specialized plant.